Project Details
Description
A Phase 1, Multi-Center, Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SL889 in Adult Patients with Stable Sickle Cell Disease
| Status | Finished |
|---|---|
| Effective start/end date | 7/10/19 → 7/31/20 |
Funding
- CSL BEHRING GMBH
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.